Abivax presents third quarter 2024 key financial information. PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – AB ...

Noble Corporation plc ("Noble", the "Company") (NYSE: NE, CSE: NOBLE) announces that today, Noble has submitted a request for the ...

Wolters Kluwer, a global leader in information, software, and services for professionals, is set to convene banking professionals and leaders at its annual Wolters Kluwer Finance, Risk and Regulatory ...

In this way, Altamir provides access to a diversified portfolio of fast-growing companies across Seven2's and Apax's sectors ...

The Company benefits from its robust Project Delivery model supported by an extensive Technology, Products and Services ...

Paris, 14 November 2024 - Net Asset Value per share stood at €35.58 as of 30 September 2024, after a dividend payment of €1.08 per share on 24 May. Including the dividend, NAV per share was up 2.9% ...

PRESS RELEASE Paris, 14 November 2024 – 5:45 pm YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE <a target=_blank href= ...

Quarter Results Abivax presents third quarter 2024 key financial information 14.11.2024 / 22:01 CET/CEST The issuer is solely responsible ...

Hargunani had been at Citi since 2000 when he joined as an ECM analyst. He was made head of the syndicate desk in 2008 and ...

Thanks to continued improvements in risk management, the impairment losses are down to 2.8% in the third quarter (Q2 2024: 3.2%). Multitude is currently well below the long-term average of 4 percent.